BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30133565)

  • 21. [Heart failure manifestation of carcinoid tricuspid dysfunction].
    Starzyk K; Gorczyca I; Wożakowska-Kapłon B
    Kardiol Pol; 2018; 76(4):808. PubMed ID: 29652428
    [No Abstract]   [Full Text] [Related]  

  • 22. Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.
    Das S; Stockton SS; Hassan SA
    Oncologist; 2023 Jul; 28(7):575-583. PubMed ID: 37209415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoid Heart Disease: a Comprehensive Review.
    Hassan SA; Palaskas NL; Agha AM; Iliescu C; Lopez-Mattei J; Chen C; Zheng H; Yusuf SW
    Curr Cardiol Rep; 2019 Nov; 21(11):140. PubMed ID: 31745664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoid heart disease: a clinical pathologic, and therapeutic update.
    Strickman NE; Rossi PA; Massumkhani GA; Hall RJ
    Curr Probl Cardiol; 1982 Feb; 6(11):1-42. PubMed ID: 7044696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinoid heart disease in patients with midgut neuroendocrine tumours.
    Delhomme C; Walter T; Arangalage D; Suc G; Hentic O; Cachier A; Alkhoder S; François L; Lombard-Bohas C; Iung B; Ruszniewski P; de Mestier L
    J Neuroendocrinol; 2023 Apr; 35(4):e13262. PubMed ID: 37005217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms.
    Boutzios G; Kaltsas G
    Front Horm Res; 2015; 44():40-57. PubMed ID: 26303703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Carcinoid tumors].
    Tóth M; Prónai L; Németh AM; Tulassay Z
    Orv Hetil; 2002 May; 143(19 Suppl):1087-92. PubMed ID: 12063867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).
    Hofland J; Lamarca A; Steeds R; Toumpanakis C; Srirajaskanthan R; Riechelmann R; Panzuto F; Frilling A; Denecke T; Christ E; Grozinsky-Glasberg S; Davar J;
    J Neuroendocrinol; 2022 Mar; 34(3):e13060. PubMed ID: 34825753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoid-syndrome: recent advances, current status and controversies.
    Ito T; Lee L; Jensen RT
    Curr Opin Endocrinol Diabetes Obes; 2018 Feb; 25(1):22-35. PubMed ID: 29120923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of carcinoid heart syndrome in patients enrolled in the SwissNet cohort.
    Grundmann E; Curioni-Fontecedro A; Christ E; Siebenhüner AR
    BMC Cancer; 2023 Apr; 23(1):338. PubMed ID: 37055717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The ectopic ACTH syndrome].
    Penezić Z; Savić S; Vujović S; Tatić S; Ercegovac M; Drezgićc M
    Srp Arh Celok Lek; 2004; 132(1-2):28-32. PubMed ID: 15227962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and biochemical aspects of the carcinoid syndrome in neuroendocrine tumors of the abdominal and retroperitoneal organs and its impact for the disease prognosis.
    Polikarpova SB; Lubimova NV; Ogereliev AS; Britvin TA; Davidov MI
    Bull Exp Biol Med; 2009 Nov; 148(5):803-6. PubMed ID: 20396797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Right ventricular failure as the presenting manifestation of a carcinoid syndrome].
    Poyet R; Kerebel S; Pons F; Aletti M; Jego C; Cellarier GR; Graffin B; Carli P; Carlioz R
    Rev Med Interne; 2009 Jan; 30(1):81-4. PubMed ID: 18468735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echocardiography in functional midgut neuroendocrine tumors: When and how often.
    Castillo JG; Naib T; Zacks JS; Adams DH
    Rev Endocr Metab Disord; 2017 Dec; 18(4):411-421. PubMed ID: 29080935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.
    Mulders MCF; de Herder WW; Hofland J
    Endocr Rev; 2024 May; 45(3):351-360. PubMed ID: 38038364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical presentation and management of carcinoid heart disease.
    Dobson R; Burgess MI; Pritchard DM; Cuthbertson DJ
    Int J Cardiol; 2014 Apr; 173(1):29-32. PubMed ID: 24636550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications of midgut carcinoid tumors and carcinoid syndrome.
    van der Horst-Schrivers AN; Wymenga AN; Links TP; Willemse PH; Kema IP; de Vries EG
    Neuroendocrinology; 2004; 80 Suppl 1():28-32. PubMed ID: 15477713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progressive dyspnoea in two patients with carcinoid syndrome].
    Nölting S; Nicolaus M; Behr J; Baumgartner R; Mete H; Boekstegers P; Herrmann K; Theisen D; Lehrke M; Göke B; Schirra J; Auernhammer CJ
    Internist (Berl); 2010 Nov; 51(11):1439-45. PubMed ID: 20628718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoid heart disease--a hidden complication of neuroendocrine tumours.
    Dero I; De Pauw M; Borbath I; Delaunoit T; Demetter P; Demolin G; Hendlisz A; Pattyn P; Pauwels S; Roeyen G; Van Cutsem E; Van Hootegem P; Van Laethem JL; Verslype C; Peeters M
    Acta Gastroenterol Belg; 2009; 72(1):34-8. PubMed ID: 19402369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.